Affordability Check
How to afford Sovaldi
Generic name: SOFOSBUVIR
Pick how you're covered. We'll show you the cheapest legitimate way to get Sovaldi — your insurance copay, manufacturer savings, charity grants, or cash price. It takes 30 seconds and we never ask for your personal information.
Pick an option above to see your specific path.
Different insurance means different laws and different savings. For example, Medicare patients cannot use manufacturer copay cards (federal law) — but the manufacturer almost always has a Patient Assistance Program that gives the drug free.
About Sovaldi and its cost
What is this medication? Sovaldi is a prescription medication used to treat chronic hepatitis C infection in adults and children at least 3 years of age. It contains the active ingredient sofosbuvir, which belongs to a class of drugs called nucleotide analog polymerase inhibitors. The medication works by directly interfering with the life cycle of the hepatitis C virus, specifically by inhibiting the protein the virus needs to replicate its genetic material. By stopping the virus from multiplying, Sovaldi helps the immune system clear the infection from the body.
This drug is generally not used as a monotherapy but is instead prescribed in combination with other antiviral medications, such as ribavirin or peginterferon alfa. The specific combination of drugs and the length of treatment are determined by the genotype of the hepatitis C virus being treated and whether the patient has developed liver complications like cirrhosis. Sovaldi represented a major advancement in medical care because it offered a more effective treatment option with fewer side effects compared to older injection-based therapies.
Sovaldi is made by Gilead Sciences. Like most brand-name drugs, it's priced at a high list price — but patients rarely pay that list price. The options above are the real paths most people use to get it affordably.
Common questions
What's the cheapest way to afford Sovaldi?
It depends on your insurance. On Medicare, apply for the manufacturer's Patient Assistance Program (PAP) — it gives the drug free if you meet income requirements. With private insurance, the manufacturer copay card usually drops your copay to $0-$25. Uninsured patients should compare the PAP with Cost Plus Drugs cash price.
Can I use a copay card with Medicare for Sovaldi?
No — federal law (the Anti-Kickback Statute) prohibits manufacturer copay cards on Medicare, Medicaid, TriCare, and VA prescriptions. But Gilead Sciences has a separate Patient Assistance Program for Medicare beneficiaries. Check the options above.
Does my Medicare Part D plan cover Sovaldi?
Part D coverage varies by plan. We query the CMS Prescription Drug Plan file to show you what percentage of plans cover it and at what tier. For your exact copay, pick "Medicare" above and check your plan's Summary of Benefits, or log in to Medicare.gov.
How long does a Patient Assistance Program take?
Most PAPs take 2-6 weeks from application to first fill. Ask the manufacturer about a "bridge supply" — many will ship 30 days free while your application is being reviewed so you don't go without the drug.
What if I have a high-deductible plan?
For generics, Cost Plus Drugs cash price is often cheaper than your deductible-phase copay. For brand names, the manufacturer copay card almost always wins. A GoodRx coupon can be a last resort for uncovered drugs, but it doesn't count toward your deductible.
Are there charity grants for Chronic Hepatitis C?
Charities like HealthWell Foundation, PAN Foundation, Good Days, and the National Organization for Rare Disorders provide copay help for specific conditions. Funds often run out mid-year — apply early. We list the specific grants for your condition in the options above.
More about Sovaldi
Full Sovaldi drug page
FDA label, prior authorization rules, full indications list
More options for Chronic Hepatitis C
Drugs, grants, and assistance for this condition
Guide to Patient Assistance Programs
How PAPs work, who qualifies, typical wait times
If your insurance denied coverage
5-level appeal playbook — Medicare has a 60% win rate at Level 3